CEACAM5 and laryngotracheoesophageal cleft: Based on the findings reported here, this study is the first to establish that serum CEA and Cyfra21-1 were able to select high-risk individuals with LC in high level radon areas, thus having the potential biomarkers to aid in the early screening and diagnosis of those at high-risk of LC.